Monday, March 15, 2010

Naltrexone and Alpha Lipoic acid for Pancreatic Cancer

In the latest issue of Integrative Cancer Therapies, a case of 3 patients with pancreatic cancer were treated with intravenous alpha lipoic acid and low dose naltrexone. What's astonishing is that the patients are still alive, 2 of which were already cancer free based on their PET scan.

This is an ongoing trial in a New Mexico Integrative Center.

I hope this study will be more available to all pancreatic cancer patients.

No comments: